好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

STN LFP and SUA characterization of dyskinesia in PD using microelectrode recordings
Movement Disorders
P4 - Poster Session 4 (5:30 PM-6:30 PM)
1-006

To describe the single unit activity (SUA) and local field potential (LFP) characteristics of a patient with idiopathic Parkinson’s disease (PD) during a dyskinesia episode.

SUA and LFPs in the unmedicated state of patients with PD undergoing deep brain stimulation (DBS) procedures are well characterized. Although LFP spectral dynamics are known to change in the ON state, less is understood about how this corresponds to changes in SUA, or how either LFP or SUA interacts during dyskinesia episodes.

We describe a case report of an individual undergoing bilateral subthalamic nucleus (STN) DBS for treatment of motor complications associated with PD. Intraoperative left hemispheric microelectrode recordings (NeuroProbe, AlphaOmega) of SUA and LFP were made simultaneously approximately 2.5 hours after the last known levodopa intake. Recordings started from 10mm above and extended to 5mm below the dorsal border of the STN. During the recordings, the patient exhibited generalized dyskinesia. 

Of 14 neurons isolated, almost all showed tonic firing (fast and some irregular) with a mean firing rate of 63.0 ± 29.8Hz, (higher than previously reported in the unmedicated state). No neurons showed bursting activity as quantified with ISI histograms showing single peaks.  LFP activity was characterized by weak beta (22Hz) oscillations, a sharp gamma (80Hz) peak, and strong high frequency oscillations (HFOs) around 300Hz. No coupling between beta and HFO was seen, as previously reported in medicated patients. The SUA was not phase coupled to beta LFP (unlike previously described unmedicated PD patients). Interestingly, sharp gamma activity commenced 10mm above the STN, indicating broader network synchronization. Contralateral dyskinesia improved during stimulation testing of the DBS lead. 

This case demonstrates unique SUA and LFP findings during a dyskinesia episode in PD, highlighting the need for a more complete understanding of local and network dynamics in PD for use in closed loop DBS systems.

 

 

Authors/Disclosures
Joohi Jimenez Shahed, MD, FAAN (Icahn School of Medicine at Mount Sinai)
PRESENTER
Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with 好色先生. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Musa Ozturk, MD (Gen Pharmaceuticals) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file